Teratogenicity of Selective Serotonin-Reuptake Inhibitors and Venlafaxine - A Population-Based Study of 2.3 Million Births in Five Nordic Countries

Furu K; Kieler H; Haglund B; Zoega H; Gissler M; Norgaard M, 2014, 'Teratogenicity of Selective Serotonin-Reuptake Inhibitors and Venlafaxine - A Population-Based Study of 2.3 Million Births in Five Nordic Countries', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. 166 - 167, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342763600315&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Opportunities (Scholarships, Grants and Research Positions)

3521284

Back to Top